Mackenzie Financial’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-560
| Closed | -$6.03K | – | 1752 |
|
|
2025
Q1 | $6.03K | Hold |
560
| – | – | ﹤0.01% | 1659 |
|
|
2024
Q4 | $7.17K | Hold |
560
| – | – | ﹤0.01% | 1690 |
|
|
2024
Q3 | $15.5K | Hold |
560
| – | – | ﹤0.01% | 1570 |
|
|
2024
Q2 | $16.2K | Hold |
560
| – | – | ﹤0.01% | 1521 |
|
|
2024
Q1 | $25K | Hold |
560
| – | – | ﹤0.01% | 1502 |
|
|
2023
Q4 | $21.7K | Hold |
560
| – | – | ﹤0.01% | 1482 |
|
|
2023
Q3 | $16.1K | Hold |
560
| – | – | ﹤0.01% | 1459 |
|
|
2023
Q2 | $34.7K | Hold |
560
| – | – | ﹤0.01% | 1478 |
|
|
2023
Q1 | $26.4K | Hold |
560
| – | – | ﹤0.01% | 1473 |
|
|
2022
Q4 | $38.9K | Hold |
560
| – | – | ﹤0.01% | 1372 |
|
|
2022
Q3 | $82K | Sell |
560
-30
| -5% | -$4.39K | ﹤0.01% | 1321 |
|
|
2022
Q2 | $77K | Buy |
+590
| New | +$77K | ﹤0.01% | 1361 |
|